Adlai Nortye Group (ANL) vs Latigo Biotherapeutics (LTGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Latigo Biotherapeutics is the larger company by market cap ($1.04 billion vs $1.02 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANL | LTGO |
|---|---|---|
| Share price | $15.85 | $15.70 |
| Market cap | $1.02B | $1.04B |
| 1-day change | +2.19% | +6.12% |
| YTD return | +992.25% | — |
| 1-year return | +796.53% | — |
| EPS (TTM) | $-0.66 | $-2.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $25.93 |
| 52-week low | $0.879 | $14.60 |
| Distance from 52-week high | -8.12% | -39.47% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +86.12% | +232.91% |
| Average volume | 187.30K | 391.26K |
| Shares outstanding | 58.73M | 66.30M |
| Employees | 109 | 66 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Adlai Nortye Group
ANL stock →Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 109 employees
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
ANL vs LTGO FAQ
Which is bigger, Adlai Nortye Group or Latigo Biotherapeutics?
Latigo Biotherapeutics (LTGO) is larger, with a market capitalization of $1.04B compared with $1.02B for Adlai Nortye Group (ANL).
Are Adlai Nortye Group and Latigo Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.